Sydney, Jan 7, 2010 (ABN Newswire) - iSOFT Group Limited (ASX:ISF) - Australia's largest listed health information technology company today welcomed the decision by the UK Financial Services Authority (FSA) to discontinue its investigation into iSOFT Group plc under S397 Financial Services & Markets Act 2000.
iSOFT Group Limited (formerly IBA Health Group Limited) acquired UK-based iSOFT Group plc in October 2007 post the events that were the subject matter of the investigation.
iSOFT Group Limited cooperated fully with the FSA throughout the investigation, which involved former management of iSOFT Group plc and had no bearing on any of the current management or employees of iSOFT Group Limited.
None of the former iSOFT Group plc directors that were investigated is employed by iSOFT Group Limited or any subsidiary of the company.
"The FSA result brings to a conclusion one of the remaining legacies of the former iSOFT which we acquired in 2007," said Gary Cohen, iSOFT Group Limited Executive Chairman & CEO. "We cooperated fully with the investigation and welcome the FSA's decision."
About iSOFT Group Limited
iSOFT Group Limited (ASX:ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.
iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.
Today, more than 13,000 provider organisations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.
A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.
Contact
Gary Cohen Executive Chairman & CEO iSOFT Group Limited Tel: +61-2-8251-6700 Email: gary.cohen@isofthealth.com
Stuart Kelly Director, Corporate Affairs iSOFT Group Limited Tel: +61-2-8251-6769 Mob: +61-404-082-361 Email: stuart.kelly@isofthealth.com
ASX:ISF) - Australia's largest listed health information technology company today welcomed the decision by the UK Financial Services Authority (FSA) to discontinue its investigation into iSOFT Group plc under S397 Financial Services & Markets Act 2000.
iSOFT Group Limited
){kind=link}